From established to emerging biomarkers – unleash the potential of comprehensive genomic profiling
When it comes to cancer, scrutinizing small molecular details can help reveal the big picture. Comprehensive genomic profiling (CGP) is gaining momentum in cancer research and testing because it allows you to develop a holistic view of a tumor’s unique blueprint. By interrogating both DNA and RNA biomarkers in parallel, you can eliminate the need for time-consuming single-gene assays and efficiently achieve deeper cancer insights.
Get up-to-speed with CGP in our complimentary ebook and explore:
- The expanding role of CGP in oncology research and testing
- Advantages of CGP over hotspot or single-marker tests
- How CGP can guide therapy selection and uncover oncogenic drivers and rare biomarkers
